Panagora Asset Management Inc Champions Oncology, Inc. Transaction History

Panagora Asset Management Inc

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 10, 2021	SELL	$9.11 - $10.96 $2,532 - $3,046	-278 Closed	0 $0
Q2 2021 Aug 11, 2021	SELL	$8.45 - $11.72 $5,467 - $7,582	-647 Reduced 69.95%	278 $3,000
Q1 2021 May 12, 2021	BUY	$10.61 - $13.75 $2,111 - $2,736	199 Added 27.41%	925 $10,000
Q4 2020 Feb 10, 2021	BUY	$8.39 - $13.27 $2,508 - $3,967	299 Added 70.02%	726 $8,000
Q3 2019 Nov 12, 2019	SELL	$5.4 - $8.99 $19,445 - $32,372	-3,601 Reduced 89.4%	427 $2,000
Q2 2019 Aug 09, 2019	SELL	$7.51 - $10.12 $2,470 - $3,329	-329 Reduced 7.55%	4,028 $32,000
Q1 2019 May 15, 2019	BUY	$7.89 - $12.23 $15,267 - $23,665	1,935 Added 79.89%	4,357 $43,000
Q4 2018 Feb 14, 2019	BUY	$7.29 - $15.27 $17,656 - $36,983	2,422 New	2,422 $19,000

5.81M

3.3K

6.1K

Ticker CSBR
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,522,400
Market Cap $53.7M
Description
Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Techn...

Get notified when there are updates to the investment portfolio of Panagora Asset Management Inc, based on Form 13F filings with the SEC.

Stay updated on Panagora Asset Management Inc with notifications on news.